However, among our heterogeneous AML cell populations neither patients with mixed leukemic phenotype nor aberrant expression of lymphoid markers (CD2, CD3, CD4, CD8, CD19, CD20) were detected. This evidence concerns the gene CD8A and acute myeloid leukemia.